3 hours Equities Analysts Issue Forecasts for ACADIA Pharmaceuticals Inc.’s Q3 2024 Earnings (NASDAQ:ACAD)MarketBeat
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) – Leerink Partnrs lifted their Q3 2024 earnings estimates for ACADIA Pharmaceuticals in a report issued on Tuesday, October 15th. Leerink Partnrs analyst M. Goodman now anticipates that the bio…
Earnings · Nasdaq 100 · Pharmaceuticals
X